Sponsor and Co-ordinationThe ARROW trial is funded by the Medical Research Council (MRC, UK) and the Department for International Development (UK). The MRC is the Sponsor of ARROW. GlaxoSmithKline Ltd supply the drugs for the trial.
It is co-ordinated by the MRC Clinical Trials Unit, London which is directly responsible to the MRC as Sponsor of the trial. MRC clinical trials are required to comply with the MRC Guidelines for Good Clinical Practice in Clinical Trials, 1998 which require structures and governing committees to be set up to monitor progress of the trial.